Patent · US Active

Compositions and methods for treating osteolytic disorders comprising MMP-14 binding proteins

US8501181B2 · kind B2 · utility

2Cited by

12References

16Claims

0Family size

Assignee

Dyax Corp. · US

Inventors

Clive Wood · Boston, US
Daniel T. Dransfield · Hanson, US
Laetitia Devy · Liège, BE

Key dates

Filing date	Dec 28, 2011
Grant date	Aug 6, 2013
Priority date	—
Expiry date	Dec 28, 2031

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T428/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are methods and compositions for using MMP-14 or MMP-9 binding proteins alone or in combination with other therapeutic agents to treat osteolytic disorders such as osteotropic cancer and osteoporosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.